At current prices Novo Nordisk is a Strong Buy. It's good positioning in the promising weight loss segment, solid foundation ...

The company raised its full-year revenue guidance from a range of $58 billion to $61 billion to a range of $60 billion to $62 billion. The midpoint suggests a 35% increase in sales for the full year.

The technology sector makes up just over a third of the S&P 500 with a 34% weighting. The tech sector includes the three ...

Some of the losses are down to pharma's broader problems: notably, President Trump's tariff and price-cut threats. But there ...

The drug, which is estimated to be taken by up to 750,000 people, is one of the country's most popular weight loss and ...

A powerful new medication is being hailed as the 'Godzilla' of weight-loss shots. It has been suggested retatrutide can help people shed a quarter of their body weight in under a year - almost twice ...

Vivienne Joy runs a community of hundreds of weight loss jab users and said the increased cost of Mounjaro had 'created chaos' ...

Included in several documents are confirmation that investigators found a second piece of a pink blanket they say belonged to ...